52 related articles for article (PubMed ID: 35729538)
21. Development and validation of reassigned CEA, CYFRA21-1 and NSE-based models for lung cancer diagnosis and prognosis prediction.
Yuan J; Sun Y; Wang K; Wang Z; Li D; Fan M; Bu X; Chen J; Wu Z; Geng H; Wu J; Xu Y; Chen M; Ren H
BMC Cancer; 2022 Jun; 22(1):686. PubMed ID: 35729538
[TBL] [Abstract][Full Text] [Related]
22. The important role of circulating CYFRA21-1 in metastasis diagnosis and prognostic value compared with carcinoembryonic antigen and neuron-specific enolase in lung cancer patients.
Zhang L; Liu D; Li L; Pu D; Zhou P; Jing Y; Yu H; Wang Y; Zhu Y; He Y; Li Y; Zhao S; Qiu Z; Li W
BMC Cancer; 2017 Feb; 17(1):96. PubMed ID: 28152979
[TBL] [Abstract][Full Text] [Related]
23. Application Value of CYFRA21-1 Combined with NSE, CEA, and SCC-Ag in Lung Cancer.
Fu Y; Li D; Zhu Y; Yan S; Wang X; Lian Z; Xie Q; He Z
Clin Lab; 2024 Apr; 70(4):. PubMed ID: 38623667
[TBL] [Abstract][Full Text] [Related]
24. The Application Value of Serum HE4 in the Diagnosis of Lung Cancer.
Wang Y; Wang Z; Ding Y; Sun F; Ding X
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2405-2407. PubMed ID: 31450913
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic Value and Clinical Significance of Combined Detection of Serum Markers CYFRA21-1, SCC Ag, NSE, CEA and ProGRP in Non-Small Cell Lung Carcinoma.
Li Q; Sang S
Clin Lab; 2020 Nov; 66(11):. PubMed ID: 33180443
[TBL] [Abstract][Full Text] [Related]
26. Stereotactic body radiotherapy versus surgery for early-stage non-small cell lung cancer: an updated meta-analysis involving 29,511 patients included in comparative studies.
Viani GA; Gouveia AG; Yan M; Matsuura FK; Moraes FY
J Bras Pneumol; 2022; 48(3):e20210390. PubMed ID: 35508065
[TBL] [Abstract][Full Text] [Related]
27. Lung Screening Benefits and Challenges: A Review of The Data and Outline for Implementation.
Sands J; Tammemägi MC; Couraud S; Baldwin DR; Borondy-Kitts A; Yankelevitz D; Lewis J; Grannis F; Kauczor HU; von Stackelberg O; Sequist L; Pastorino U; McKee B
J Thorac Oncol; 2021 Jan; 16(1):37-53. PubMed ID: 33188913
[TBL] [Abstract][Full Text] [Related]
28. State Variation in Low-Dose Computed Tomography Scanning for Lung Cancer Screening in the United States.
Fedewa SA; Kazerooni EA; Studts JL; Smith RA; Bandi P; Sauer AG; Cotter M; Sineshaw HM; Jemal A; Silvestri GA
J Natl Cancer Inst; 2021 Aug; 113(8):1044-1052. PubMed ID: 33176362
[TBL] [Abstract][Full Text] [Related]
29. Possible role of circulating tumor cells in early detection of lung cancer.
Poggiana C; Rossi E; Zamarchi R
J Thorac Dis; 2020 Jul; 12(7):3821-3835. PubMed ID: 32802464
[TBL] [Abstract][Full Text] [Related]
30. Systematic review and meta-analysis on the impact of lung cancer screening by low-dose computed tomography.
Sadate A; Occean BV; Beregi JP; Hamard A; Addala T; de Forges H; Fabbro-Peray P; Frandon J
Eur J Cancer; 2020 Jul; 134():107-114. PubMed ID: 32502939
[TBL] [Abstract][Full Text] [Related]
31. Lung Cancer 2020: Epidemiology, Etiology, and Prevention.
Bade BC; Dela Cruz CS
Clin Chest Med; 2020 Mar; 41(1):1-24. PubMed ID: 32008623
[TBL] [Abstract][Full Text] [Related]
32. Serum CEA levels in 49 different types of cancer and noncancer diseases.
Hao C; Zhang G; Zhang L
Prog Mol Biol Transl Sci; 2019; 162():213-227. PubMed ID: 30905451
[TBL] [Abstract][Full Text] [Related]
33. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Bray F; Ferlay J; Soerjomataram I; Siegel RL; Torre LA; Jemal A
CA Cancer J Clin; 2018 Nov; 68(6):394-424. PubMed ID: 30207593
[TBL] [Abstract][Full Text] [Related]
34. The Prognostic Role of Circulating Tumor Cells (CTCs) in Lung Cancer.
Kapeleris J; Kulasinghe A; Warkiani ME; Vela I; Kenny L; O'Byrne K; Punyadeera C
Front Oncol; 2018; 8():311. PubMed ID: 30155443
[TBL] [Abstract][Full Text] [Related]
35. Thymidine kinase 1 combined with CEA, CYFRA21-1 and NSE improved its diagnostic value for lung cancer.
Jiang ZF; Wang M; Xu JL
Life Sci; 2018 Feb; 194():1-6. PubMed ID: 29247745
[TBL] [Abstract][Full Text] [Related]
36. Low-dose CT for lung cancer screening: opportunities and challenges.
Shen H
Front Med; 2018 Feb; 12(1):116-121. PubMed ID: 29218678
[TBL] [Abstract][Full Text] [Related]
37. Progress and prospects of early detection in lung cancer.
Blandin Knight S; Crosbie PA; Balata H; Chudziak J; Hussell T; Dive C
Open Biol; 2017 Sep; 7(9):. PubMed ID: 28878044
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
